Back to UBS Group AG UBS Group AG

VYNEVYNE
Showing 8 of 23 quarters

Position history for UBS Group AGUBS Group AG's holdings in VYNE THERAPEUTICS INC

UBS Group AG holds 179,784 shares of VYNE (VYNE THERAPEUTICS INC), worth $107,511 as of 2026-Q1. The position was increased (+186.5% shares).

Current Value

$107,511

Current Shares

179,784

Total Value Change

+$58,146

Total Shares Change

+154,726

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
179,784
+186.5%
$107,5110.0%$0.60
24
2025-Q4
Increased
62,761
+1026.4%
$36,4010.0%$0.58
22
2025-Q3
New
5,572
-
$1,8660.0%$0.34
17
2025-Q2
Exited
0
-100.0%
$00.0%$1.65
0
2025-Q1
Increased
7,576
+1100.6%
$11,9700.0%$1.58
19
2024-Q4
Increased
631
+4407.1%
$2,1140.0%$3.35
13
2024-Q3
Decreased
14
-99.9%
$260.0%$1.88
0
2024-Q2
Increased
25,058
+1565x
$49,3650.0%$1.97
23

Other major holders of VYNE: FRANKLIN RESOURCES INC, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used